{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:49:44Z","timestamp":1767142184313,"version":"build-2238731810"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11906-021-01134-9","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T19:18:05Z","timestamp":1616699885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Renin-Angiotensin System, Hypertension, and SARS-CoV-2 Infection: a Review"],"prefix":"10.1007","volume":"23","author":[{"given":"Premjith","family":"Gathiram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Mackraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-9364","authenticated-orcid":false,"given":"Jagidesa","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"key":"1134_CR1","doi-asserted-by":"crossref","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected 2020. Available from: https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.","DOI":"10.15557\/PiMR.2020.0003"},{"issue":"4","key":"1134_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/01.NAJ.0000659956.26994.75","volume":"120","author":"C Editor","year":"2020","unstructured":"Clinical Editor. As we went to press: COVID-19 continues to spread. Am J Nurs. 2020;120(4):15.","journal-title":"Am J Nurs"},{"issue":"6965","key":"1134_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450\u20134.","journal-title":"Nature"},{"issue":"1","key":"1134_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","volume":"9","author":"MY Li","year":"2020","unstructured":"Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45.","journal-title":"Infect Dis Poverty"},{"key":"1134_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biochi.2020.04.008","volume":"174","author":"M Alifano","year":"2020","unstructured":"Alifano M, Alifano P, Forgez P, Iannelli A. Renin-angiotensin system at the heart of COVID-19 pandemic. Biochimie. 2020;174:30\u20133.","journal-title":"Biochimie"},{"issue":"10226","key":"1134_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(20)30360-3","volume":"395","author":"H Chen","year":"2020","unstructured":"Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809\u201315.","journal-title":"Lancet"},{"key":"1134_CR7","unstructured":"World Health Organization. Coronavirus 2020 [cited 2020 18 April]. https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_1."},{"issue":"5","key":"1134_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11886-020-01292-3","volume":"22","author":"H Zhu","year":"2020","unstructured":"Zhu H, Rhee JW, Cheng P, Waliany S, Chang A, Witteles RM, et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr Cardiol Rep. 2020;22(5):32.","journal-title":"Curr Cardiol Rep"},{"key":"1134_CR9","doi-asserted-by":"crossref","unstructured":"Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020;200642.","DOI":"10.1148\/radiol.2020200642"},{"issue":"3","key":"1134_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4274\/balkanmedj.galenos.2020.2020.2.15","volume":"37","author":"P An","year":"2020","unstructured":"An P, Song P, Lian K, Wang Y. CT Manifestations of novel coronavirus pneumonia: a case report. Balkan Med J. 2020;37(3):163\u20135.","journal-title":"Balkan Med J"},{"issue":"2","key":"1134_CR11","doi-asserted-by":"publisher","first-page":"e20200114","DOI":"10.36416\/1806-3756\/e20200114","volume":"46","author":"JAB Araujo-Filho","year":"2020","unstructured":"Araujo-Filho JAB, Sawamura MVY, Costa AN, Cerri GG, Nomura CH. COVID-19 pneumonia: what is the role of imaging in diagnosis? J Bras Pneumol. 2020;46(2):e20200114.","journal-title":"J Bras Pneumol"},{"key":"1134_CR12","doi-asserted-by":"crossref","unstructured":"Zhou Z, Guo D, Li C, Fang Z, Chen L, Yang R, et al. Coronavirus disease 2019: initial chest CT findings. Eur Radiol. 2020.","DOI":"10.1007\/s00330-020-06816-7"},{"issue":"6","key":"1134_CR13","first-page":"3404","volume":"24","author":"F Zheng","year":"2020","unstructured":"Zheng F, Tang W, Li H, Huang YX, Xie YL, Zhou ZG. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020;24(6):3404\u201310.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"1134_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1210\/er.2003-0001","volume":"24","author":"RM Carey","year":"2003","unstructured":"\u2022\u2022 Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev. 2003;24(3):261\u201371 This article focuses on the actions of RAS in circulation and in tissues.","journal-title":"Endocr Rev"},{"issue":"8","key":"1134_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/ajh.2011.246","volume":"25","author":"A Kurtz","year":"2012","unstructured":"Kurtz A. Control of renin synthesis and secretion. Am J Hypertens. 2012;25(8):839\u201347.","journal-title":"Am J Hypertens"},{"key":"1134_CR16","doi-asserted-by":"crossref","unstructured":"D\u2019Ardes D, Boccatonda A, Rossi I, Guagnano MT, Santilli F, Cipollone F, et al. COVID-19 and RAS: unravelling an unclear relationship. Int J Mol Sci. 2020;21(8).","DOI":"10.3390\/ijms21083003"},{"issue":"1","key":"1134_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.2162","volume":"212","author":"I Hamming","year":"2007","unstructured":"Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1\u201311.","journal-title":"J Pathol"},{"key":"1134_CR18","unstructured":"de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52(3):415\u201372."},{"issue":"8 Suppl 4","key":"1134_CR19","doi-asserted-by":"publisher","first-page":"IV56","DOI":"10.1002\/clc.4960141809","volume":"14","author":"CM Ferrario","year":"1991","unstructured":"Ferrario CM, Jaiswal N, Yamamoto K, Diz DI, Schiavone MT. Hypertensive mechanisms and converting enzyme inhibitors. Clin Cardiol. 1991;14(8 Suppl 4):IV56\u201362 discussion IV83-90.","journal-title":"Clin Cardiol"},{"issue":"22","key":"1134_CR20","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMcibr022472","volume":"347","author":"M Boehm","year":"2002","unstructured":"\u2022\u2022 Boehm M, Nabel EG. Angiotensin-converting enzyme 2--a new cardiac regulator. N Engl J Med. 2002;347(22):1795\u20137 This article discusses the role of ACE in blood pressure and the use of ACE inhibitors to lower blood pressure in patients with cardiovascular conditions and hypertension.","journal-title":"N Engl J Med"},{"key":"1134_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.abb.2019.03.004","volume":"665","author":"L Reyes","year":"2019","unstructured":"Reyes L, Hawkins CL, Rayner BS. Characterization of the cellular effects of myeloperoxidase-derived oxidants on H9c2 cardiac myoblasts. Arch Biochem Biophys. 2019;665:132\u201342.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"1134_CR22","doi-asserted-by":"publisher","first-page":"F521","DOI":"10.1152\/ajprenal.00029.2018","volume":"315","author":"ADM Riquier-Brison","year":"2018","unstructured":"Riquier-Brison ADM, Sipos A, Prokai A, Vargas SL, Toma L, Meer EJ, et al. The macula densa prorenin receptor is essential in renin release and blood pressure control. Am J Physiol Renal Physiol. 2018;315(3):F521\u2013F34.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6891","key":"1134_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","volume":"417","author":"MA Crackower","year":"2002","unstructured":"\u2022\u2022 Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417(6891):822\u20138 This study indicates that a mutation on the X chromosome of ACE2 is associted with severe heart defects in Rat models.","journal-title":"Nature"},{"issue":"3","key":"1134_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5830\/CVJA-2019-025","volume":"30","author":"B Rayner","year":"2019","unstructured":"Rayner B, Jones E, Veriava Y, Seedat YK. South African Hypertension Society commentary on the American College of Cardiology\/American Heart Association hypertension guidelines. Cardiovasc J Afr. 2019;30(3):184\u20137.","journal-title":"Cardiovasc J Afr"},{"issue":"1","key":"1134_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI112768","volume":"79","author":"DJ Campbell","year":"1987","unstructured":"Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest. 1987;79(1):1\u20136.","journal-title":"J Clin Invest"},{"issue":"5","key":"1134_CR26","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1\u20139.","journal-title":"Circ Res"},{"issue":"43","key":"1134_CR27","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238\u201343.","journal-title":"J Biol Chem"},{"issue":"21","key":"1134_CR28","doi-asserted-by":"publisher","first-page":"R745","DOI":"10.1016\/S0960-9822(02)01255-1","volume":"12","author":"U Eriksson","year":"2002","unstructured":"Eriksson U, Danilczyk U, Penninger JM. Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol. 2002;12(21):R745\u201352.","journal-title":"Curr Biol"},{"issue":"1-2","key":"1134_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(02)03640-2","volume":"532","author":"D Harmer","year":"2002","unstructured":"Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002;532(1-2):107\u201310.","journal-title":"FEBS Lett"},{"issue":"2","key":"1134_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631\u20137.","journal-title":"J Pathol"},{"issue":"6","key":"1134_CR31","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.mayocp.2020.03.026","volume":"95","author":"F Sanchis-Gomar","year":"2020","unstructured":"Sanchis-Gomar F, Lavie CJ, Perez-Quilis C, Henry BM, Lippi G. Angiotensin-converting enzyme 2 and antihypertensives (angiotensin receptor blockers and angiotensin-converting enzyme inhibitors) in coronavirus disease 2019. Mayo Clin Proc. 2020;95(6):1222\u201330.","journal-title":"Mayo Clin Proc"},{"issue":"6485","key":"1134_CR32","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444\u20138.","journal-title":"Science"},{"issue":"5","key":"1134_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","volume":"134","author":"D Batlle","year":"2020","unstructured":"Batlle D, Wysocki J, Satchell K. Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? Clin Sci (Lond). 2020;134(5):543\u20135.","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"1134_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1139\/y02-021","volume":"80","author":"AJ Turner","year":"2002","unstructured":"Turner AJ, Tipnis SR, Guy JL, Rice G, Hooper NM. ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol. 2002;80(4):346\u201353.","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"1134_CR35","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/HYPERTENSIONAHA.106.076216","volume":"50","author":"MC Chappell","year":"2007","unstructured":"Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension. 2007;50(4):596\u20139.","journal-title":"Hypertension"},{"issue":"17","key":"1134_CR36","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.2018.16755","volume":"320","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Williams B. The 2018 European Society of Cardiology\/European Society of Hypertension and 2017 American College of Cardiology\/American Heart Association blood pressure guidelines: more similar than different. JAMA. 2018;320(17):1749\u201350.","journal-title":"JAMA"},{"issue":"2","key":"1134_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/sj.jhh.1000773","volume":"13","author":"YK Seedat","year":"1999","unstructured":"Seedat YK. Hypertension in black South Africans. J Hum Hypertens. 1999;13(2):96\u2013103.","journal-title":"J Hum Hypertens"},{"issue":"6","key":"1134_CR38","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"1","key":"1134_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13054-020-02862-1","volume":"24","author":"LW Busse","year":"2020","unstructured":"Busse LW, Chow JH, McCurdy MT, Khanna AK. COVID-19 and the RAAS-a potential role for angiotensin II? Crit Care. 2020;24(1):136.","journal-title":"Crit Care"},{"key":"1134_CR40","doi-asserted-by":"publisher","first-page":"m1313","DOI":"10.1136\/bmj.m1313","volume":"369","author":"JK Aronson","year":"2020","unstructured":"Aronson JK, Ferner RE. Drugs and the renin-angiotensin system in covid-19. BMJ. 2020;369:m1313.","journal-title":"BMJ"},{"key":"1134_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ddr.21656","volume":"81","author":"D Gurwitz","year":"2020","unstructured":"Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020;81:537\u201340.","journal-title":"Drug Dev Res."},{"issue":"20","key":"1134_CR42","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"\u2022\u2022 Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111(20):2605\u201310 This study discusses the effects of ACE2 inhibitors and Ang II blockers on the the ACE2 gene activity, blood pressure regulation, and Ang (1-7).","journal-title":"Circulation"},{"key":"1134_CR43","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"1134_CR44","doi-asserted-by":"publisher","first-page":"H1080","DOI":"10.1152\/ajpheart.00215.2020","volume":"318","author":"Z Abassi","year":"2020","unstructured":"Abassi Z, Assady S, Khoury EE, Heyman SN. Letter to the Editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications. Am J Physiol Heart Circ Physiol. 2020;318(5):H1080\u2013H3.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1134_CR45","doi-asserted-by":"crossref","unstructured":"Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA. 2020","DOI":"10.1001\/jama.2020.4812"},{"issue":"5","key":"1134_CR46","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/HJH.0000000000002450","volume":"38","author":"M Esler","year":"2020","unstructured":"Esler M, Esler D. Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? J Hypertens. 2020;38(5):781\u20132.","journal-title":"J Hypertens"},{"key":"1134_CR47","doi-asserted-by":"crossref","unstructured":"Battistoni A, Volpe M. Might renin-angiotensin system blockers play a role in the COVID-19 pandemic? Eur Heart J Cardiovasc Pharmacother. 2020.","DOI":"10.1093\/ehjcvp\/pvaa030"},{"issue":"2-3","key":"1134_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ando.2020.04.005","volume":"81","author":"J Alexandre","year":"2020","unstructured":"Alexandre J, Cracowski JL, Richard V, Bouhanick B, Drugs C-wFSPT. Renin-angiotensin-aldosterone system and COVID-19 infection. Ann Endocrinol (Paris). 2020;81(2-3):63\u20137.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"1134_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","volume":"21","author":"H Zhang","year":"2017","unstructured":"Zhang H, Baker A. Recombinant human ACE2: acing out angiotensin II in ARDS therapy. Crit Care. 2017;21(1):305.","journal-title":"Crit Care"},{"key":"1134_CR50","doi-asserted-by":"crossref","unstructured":"Rossi GP, Sanga V, Barton M. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients. Elife. 2020;9.","DOI":"10.7554\/eLife.57278"},{"issue":"19","key":"1134_CR51","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","volume":"41","author":"GM Kuster","year":"2020","unstructured":"Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020;41(19):1801\u20133.","journal-title":"Eur Heart J"},{"issue":"12","key":"1134_CR52","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020;126(12):1671\u201381.","journal-title":"Circ Res"},{"key":"1134_CR53","doi-asserted-by":"crossref","unstructured":"Perico L, Benigni A, Remuzzi G. Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade. Nephron. 2020:1\u20139.","DOI":"10.1159\/000507305"},{"issue":"7","key":"1134_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016509","volume":"9","author":"R Sommerstein","year":"2020","unstructured":"Sommerstein R, Kochen MM, Messerli FH, Grani C. Coronavirus disease 2019 (COVID-19): do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect? J Am Heart Assoc. 2020;9(7):e016509.","journal-title":"J Am Heart Assoc"},{"issue":"10238","key":"1134_CR55","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0140-6736(20)31131-4","volume":"395","author":"B Williams","year":"2020","unstructured":"Williams B, Zhang Y. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet. 2020;395(10238):1671\u20133.","journal-title":"Lancet"},{"issue":"22","key":"1134_CR56","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/eurheartj\/ehaa423","volume":"41","author":"TJ John","year":"2020","unstructured":"John TJ, John K. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Eur Heart J. 2020;41(22):2126\u20137.","journal-title":"Eur Heart J"},{"issue":"7798","key":"1134_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.","journal-title":"Nature"},{"key":"1134_CR58","unstructured":"Cardiology ESo. Position statement of the ESC Council on Hypertension on ACE-inhibitors and angiotensin receptor blockers [cited 2020 13 March]. Available from: https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang."},{"key":"1134_CR59","unstructured":"HFSA\/ACC\/AHA. Statement addresses concerns re: using RAAS antagonists in COVID-19 2020 [cited 2020 30 August]. Available from: https:\/\/www.acc.org\/latest-in-cardiology\/articles\/2020\/03\/17\/08\/59\/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19."},{"key":"1134_CR60","unstructured":"International Society of Hypertension. A statement from the International Society of Hypertension on COVID-19 2020. Available from: https:\/\/ish-world.com\/news\/a\/A-statement-from-the-International-Society-of-Hypertension-on-COVID-19\/."},{"issue":"4","key":"1134_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.dsx.2020.04.019","volume":"14","author":"E Cure","year":"2020","unstructured":"Cure E, Cumhur CM. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes Metab Syndr. 2020;14(4):349\u201350.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"1134_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.","journal-title":"Lancet Respir Med"},{"key":"1134_CR63","doi-asserted-by":"crossref","unstructured":"Diaz JH. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med. 2020;27.","DOI":"10.1093\/jtm\/taaa041"},{"key":"1134_CR64","doi-asserted-by":"crossref","unstructured":"Emilsson V, Gudmundsson EF, Aspelund T, Jonsson BG, Gudjonsson A, Launer LJ, et al. Antihypertensive medication uses and serum ACE2 levels: ACEIs\/ARBs treatment does not raise serum levels of ACE2. medRxiv. 2020.","DOI":"10.1101\/2020.05.21.20108738"},{"issue":"19","key":"1134_CR65","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","volume":"41","author":"IE Sama","year":"2020","unstructured":"Sama IE, Ravera A, Santema BT, van Goor H, Ter Maaten JM, Cleland JGF, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020;41(19):1810\u20137.","journal-title":"Eur Heart J"},{"issue":"7","key":"1134_CR66","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016219","volume":"9","author":"J Guo","year":"2020","unstructured":"Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc. 2020;9(7):e016219.","journal-title":"J Am Heart Assoc"},{"key":"1134_CR67","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYPERTENSIONAHA.120.15572","volume":"76","author":"X Guo","year":"2020","unstructured":"Guo X, Zhu Y, Hong Y. Decreased mortality of COVID-19 with renin-angiotensin-aldosterone system inhibitors therapy in patients with hypertension: a meta-analysis. Hypertension. 2020;76:e13\u20134.","journal-title":"Hypertension"},{"issue":"6","key":"1134_CR68","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"AHJ Danser","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020;75(6):1382\u20135.","journal-title":"Hypertension"},{"issue":"7","key":"1134_CR69","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41440-020-0455-8","volume":"43","author":"H Kai","year":"2020","unstructured":"Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res. 2020;43(7):648\u201354.","journal-title":"Hypertens Res"},{"key":"1134_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020;76:14\u201320.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1134_CR71","first-page":"613","volume":"32","author":"Y Fang","year":"2020","unstructured":"Fang Y, Guo Z, Chai Y, Zhang H, Wang Z. 2019 Novel coronavirus, renin-angiotension system imbalance and coronavirus disease 2019. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32(5):613\u20137.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"1134_CR72","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cpt.1863","volume":"108","author":"K Sriram","year":"2020","unstructured":"Sriram K, Insel PA. Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence. Clin Pharmacol Ther. 2020;108:236\u201341.","journal-title":"Clin Pharmacol Ther."},{"key":"1134_CR73","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","volume":"5","author":"N Mehta","year":"2020","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, et al. Association of use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1020\u20136.","journal-title":"JAMA Cardiol"},{"issue":"10238","key":"1134_CR74","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","volume":"395","author":"FJ de Abajo","year":"2020","unstructured":"de Abajo FJ, Rodriguez-Martin S, Lerma V, Mejia-Abril G, Aguilar M, Garcia-Luque A, et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395(10238):1705\u201314.","journal-title":"Lancet"},{"key":"1134_CR75","doi-asserted-by":"crossref","unstructured":"Felice C, Nardin C, Di Tanna GL, Grossi U, Bernardi E, Scaldaferri L, et al. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives. Am J Hypertens. 2020.","DOI":"10.1093\/ajh\/hpaa096"},{"key":"1134_CR76","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","volume":"76","author":"G Yang","year":"2020","unstructured":"Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, et al. Effects of ARBs and ACEIs on virus infection, inflammatory status and clinical outcomes in COVID-19 patients with hypertension: a single center retrospective study. Hypertension. 2020;76:51\u20138.","journal-title":"Hypertension"},{"key":"1134_CR77","doi-asserted-by":"crossref","unstructured":"Khera R, Clark C, Lu Y, Guo Y, Ren S, Truax B, et al. Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with coronavirus disease-19. medRxiv. 2020.","DOI":"10.1101\/2020.05.17.20104943"},{"issue":"25","key":"1134_CR78","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382(25):2441\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"1134_CR79","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, et al. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9(1):757\u201360.","journal-title":"Emerg Microbes Infect"},{"key":"1134_CR80","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ejhf.1924","volume":"22","author":"DM Bean","year":"2020","unstructured":"Bean DM, Kraljevic Z, Searle T, Bendayan R, Kevin OG, Pickles A, et al. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust. Eur J Heart Fail. 2020;22:967\u201374.","journal-title":"Eur J Heart Fail"},{"key":"1134_CR81","doi-asserted-by":"crossref","unstructured":"Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020.","DOI":"10.1001\/jamacardio.2020.1624"},{"issue":"0","key":"1134_CR82","first-page":"E004","volume":"48","author":"YD Peng","year":"2020","unstructured":"Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY, et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(0):E004.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"1134_CR83","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","volume":"382","author":"G Mancia","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382:2431\u201340.","journal-title":"N Engl J Med"},{"issue":"2","key":"1134_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40292-020-00380-3","volume":"27","author":"G Iaccarino","year":"2020","unstructured":"Iaccarino G, Borghi C, Cicero AFG, Ferri C, Minuz P, Muiesan ML, et al. Renin-angiotensin system inhibition in cardiovascular patients at the time of COVID19: much ado for nothing? A statement of activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev. 2020;27(2):105\u20138.","journal-title":"High Blood Press Cardiovasc Prev"}],"updated-by":[{"DOI":"10.1007\/s11906-021-01145-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000}}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01134-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11906-021-01134-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-021-01134-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T06:13:37Z","timestamp":1675059217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11906-021-01134-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":84,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1007\/s11906-021-01134-9","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"23 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11906-021-01145-6","URL":"https:\/\/doi.org\/10.1007\/s11906-021-01145-6","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"17"}}